Wearable Artificial Intelligence for Detecting Anxiety: Systematic Review and Meta-Analysis

Current clinical practices for identifying mental distress rely heavily on patient self-reports or clinician interviews. These traditional methods frequently suffer from subjective bias and require significant time commitments from both parties. That uncertainty drove interest in developing automated, objective monitoring tools. Wearable artificial intelligence represents a fusion of portable sensors and machine learning algorithms. This technology aims to provide continuous, real-time insights into a user's emotional state. Despite widespread interest, the actual diagnostic precision of these integrated systems remains unclear. No prior work had resolved whether these digital tools could reliably replace standard diagnostic procedures. This systematic review addresses the gap by synthesizing performance metrics across existing literature.

This systematic review and meta-analysis aims to assess the performance of wearable artificial intelligence in detecting and predicting anxiety. The authors sought to address the limitations of traditional, subjective clinical assessment methods. By synthesizing existing data, they intended to determine if digital tools could provide objective, efficient alternatives. The study focuses on identifying the current diagnostic capabilities of these integrated hardware and software systems. This investigation was motivated by the increasing demand for early and automated detection of mental health conditions. The researchers aimed to clarify whether current technology is sufficiently advanced for widespread clinical implementation. They also sought to identify specific factors that might influence the diagnostic precision of these devices. This work provides a necessary evaluation of the current state of digital mental health monitoring.

The review approach involved searching eight distinct electronic databases to identify relevant literature. Two independent reviewers performed the selection process to maintain high standards of rigor. These investigators also conducted data extraction and evaluated the risk of bias for each paper. The team applied a modified version of the Quality Assessment of Diagnostic Accuracy Studies-Revised framework. They synthesized the gathered evidence using both narrative descriptions and statistical meta-analysis techniques. This dual strategy allowed for a comprehensive examination of performance metrics across the included studies. The authors performed subgroup analyses to determine if various factors moderated the observed diagnostic outcomes. This methodology ensured that the final conclusions were based on a robust and transparent synthesis of existing data.

Key findings from the literature indicate a pooled mean accuracy of 0.82 across the majority of analyzed studies. The meta-analysis of these records yielded a pooled mean sensitivity of 0.79. Researchers also calculated a pooled mean specificity of 0.92 for the evaluated systems. Subgroup analyses demonstrated that performance metrics remained stable regardless of the specific algorithms employed. The diagnostic effectiveness did not vary based on the types of wearable devices or data sources used. Validation methods and reference standards also failed to moderate the observed performance of these digital tools. These results were derived from twenty-one studies that met the inclusion criteria from an initial pool of 918 records. The data suggest that while these systems show promise, their current performance is consistent across various technical configurations.

The authors suggest that current digital monitoring tools possess potential for identifying emotional distress. These systems do not yet meet the rigorous standards required for standalone clinical applications. Practitioners should continue utilizing established diagnostic protocols alongside any digital monitoring outputs. Future development must focus on creating hardware capable of identifying precise daily moments of heightened distress. Researchers should also prioritize distinguishing between various forms of emotional disorders in upcoming trials. Investigating how combining sensor data with brain imaging might improve detection accuracy remains a priority. Manufacturers need to refine device sensitivity to ensure more reliable performance across diverse populations. These findings emphasize that digital health solutions currently serve as supportive tools rather than definitive diagnostic replacements.